Evidence map›Paper›PMID 31938879›Full record

ReviewPsychopharmacology2021

Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment.

Beata R Godlewska, Catherine J Harmer

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05680220 narecruitingnot on this mapstarted 2023, after this paper: background citation

A Double-blinded, Randomized Placebo-controlled Trial of 40 Hz Light Neurostimulation Therapy for Patients With Depression

TypeinterventionalSponsorKlaus MartinyRan2023 to 2027Enrolled60ConditionsMajor Depressive Disorder, Treatment Resistant DepressionArmsNeurostimulation System (NSS): Active Setting, Neurostimulation System (NSS): Sham Setting
NCT06363487 nacompletednot on this mapstarted 2024, after this paper: background citation

Effects of Single-dose Semaglutide on Cognition and Energy in Healthy Volunteers

TypeinterventionalSponsorUniversity of OxfordRan2024 to 2024Enrolled70ConditionsCognitive ChangeArmsSemaglutide, 0.5 mg/mL, Placebo, 0.9% NaCl 1.5mL
3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.Journal of the American Academy of Child and Adolescent Psychiatry · 2021
    Trial
  16. Acute effects of ATNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  17. Negative affect interacts with perceptual affective biases.Journal of psychopharmacology (Oxford, England) · 2026
    Article
  18. Article
  19. Article
  20. Early effects of a novel 5-HTThe British journal of psychiatry : the journal of mental science · 2026
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Beata R GodlewskaDepartment of Psychiatry, Psychopharmacology Research Unit, University Department of Psychiatry (PPRU), University of Oxford, Oxford, UK. beata.godlewska@psych.ox.ac.uk.ORCID http://orcid.org/0000-0002-5973-3765
Catherine J HarmerDepartment of Psychiatry, Psychopharmacology and Emotion Research Laboratory (PERL), University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is a leading cause of disability worldwide and improving its treatment is a core research priority for future programmes. A change in the view of psychological and biological processes, from seeing them as separate to complementing one another, has introduced new perspectives on pathological mechanisms of depression and treatment mode of action. This review presents a theoretical model that incorporated this novel approach, the cognitive neuropsychological hypothesis of antidepressant action. This model proposes that antidepressant treatments decrease the negative bias in the processing of emotionally salient information early in the course of antidepressant treatment, which leads to the clinically significant mood improvement later in treatment. The paper discusses the role of negative affective biases in the development of depression and response to antidepressant treatments. It also discusses whether the model can be applied to other antidepressant interventions and its potential translational value, including treatment choice, prediction of response and drug development.

Indexed as

AffectAntidepressive AgentsCognitionDepressionEmotionsHumansAntidepressive AgentsAntidepressant responseCognitive neuropsychological modelEmotional processingNegative bias

Identifiers

PMID31938879
PMCPMC8062380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.